What is the price target for SION stock?
16 analysts have analysed SION and the average price target is 45.75 USD. This implies a price increase of 33.01% is expected in the next year compared to the current price of 34.4.
SIONNA THERAPEUTICS INC (SION) Forecast, Price Target & Analyst Ratings
NASDAQ:SION • US8294011080
Current stock price
34.4 USD
-1.44 (-4.02%)
At close:
34.4 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SIONNA THERAPEUTICS INC (SION).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.52
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$45.75
Upside
+ 33.01%
From current price of $34.40 to mean target of $45.75, Based on 16 analyst forecasts
Low
$24.24
Median
$45.90
High
$60.90
Price Target Revisions
1 Month
0.00%
3 Months
5.37%
Price Target Summary
16 Wall Street analysts provided a forecast for the next 12 months for SION. The average price target is 45.75 USD. This implies a price increase of 33.01% is expected in the next year compared to the current price of 34.4.
The average price target has been revised upward by 5.37% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.75%
SION was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SION.
In the previous month the buy percentage consensus was at a similar level.
SION was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | Guggenheim | Maintains | Buy -> Buy |
| 2026-03-02 | BTIG | Reiterate | Buy -> Buy |
| 2026-02-24 | Citizens | Initiate | Market Outperform |
| 2026-01-14 | BTIG | Reiterate | Buy -> Buy |
| 2026-01-07 | BTIG | Maintains | Buy -> Buy |
| 2025-12-23 | LifeSci Capital | Initiate | Outperform |
| 2025-12-01 | RBC Capital | Downgrade | Sector Perform -> Underperform |
| 2025-11-19 | BTIG | Initiate | Buy |
| 2025-10-17 | Freedom Capital Markets | Initiate | Buy |
| 2025-09-08 | Jones Trading | Initiate | Buy |
| 2025-09-03 | RBC Capital | Initiate | Sector Perform |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-03-04 | Stifel | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.52
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 15.33%
- Number of Analysts
- 11
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.67%
EPS (3 Months)
-0.15%
Next Earnings Summary
SION is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.52 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 50.00% | N/A 443.33% | N/A 103.57% | N/A 262.19% | N/A 103.13% | N/A 82.46% | ||||
| EBITDA YoY % growth | -41.25M | -49.75M -20.61% | -69.888M -40.48% | N/A -30.09% | N/A -32.96% | N/A -17.15% | N/A -18.96% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -41.372M | -50.333M -21.66% | -70.556M -40.18% | N/A -32.94% | N/A -24.04% | N/A -12.65% | N/A -18.72% | N/A -0.49% | N/A 4.86% | N/A 57.00% | N/A 143.06% | N/A 944.65% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.95 12.10% | N/A -17.56% | N/A -12.92% | N/A -4.43% | N/A -12.00% | N/A -7.65% | N/A 37.56% | N/A 118.42% | N/A 1,093.47% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 15.33% | -0.58 -41.80% | -0.59 -29.05% | -0.59 -29.35% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -25.56M -31.08% | -27.883M -29.09% | -30.45M -30.63% | N/A |
| EBIT Q2Q % growth | -26.456M -34.57% | -29.275M -33.64% | -30.927M -29.92% | -32.61M -20.64% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-11.50%
EPS Next 5 Year
-10.82%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-25.24%
EBIT Next 5 Year
-23.64%
SIONNA THERAPEUTICS INC / SION Forecast FAQ
What is the next earnings date for SION stock?
SIONNA THERAPEUTICS INC (SION) will report earnings on 2026-05-04.
Can you provide the consensus estimates for SIONNA THERAPEUTICS INC next earnings?
The consensus EPS estimate for the next earnings of SIONNA THERAPEUTICS INC (SION) is -0.52 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for SION stock?
The consensus rating for SIONNA THERAPEUTICS INC (SION) is 83.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.